{"brief_title": "Safety and Tolerability Study of Drug to Treat Schizophrenia", "brief_summary": "The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.", "condition": ["Schizophrenia"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["Lurasidone 20 mg", "Lurasidone 40 mg", "Lurasidone 80mg"], "description": ["Lurasidone 20mg oral tablet taken once daily for 6-months", "Lurasidone 40mg oral tablets taken once daily", "Lurasidone 80mg oral tablet taken once daily"], "arm_group_label": ["Lurasidone 20 mg", "Lurasidione 40 mg", "Lurasidone 80mg"], "criteria": "Inclusion criteria: - Successful completion of participation in protocol #D1050049 Exclusion criteria: - Substance abuse - Prolactin level of \u2265200ng/mL at baseline - Pregnancy", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "Lurasidone", "mesh_term": ["Schizophrenia", "Lurasidone Hydrochloride"], "id": "NCT00044005"}